Insider holders · CIK 0001662524
AKCEA THERAPEUTICS, INC. · AKCA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC10% Owner | 67,383,965 | — | 67,383,965 | Oct 18, 2018 · 8:05 pm EDT | Form 4 |
| Sarah BoycePresident | 20,894 | — | 20,894 | Apr 18, 2018 · 1:00 pm EDT | Form 4 |
| Jeff Marc GoldbergChief Operating Officer | 2,880 | — | 2,880 | Jan 4, 2019 · 5:33 pm EST | Form 4 |
| Paula SoteropoulosChief Executive Officer | 0 | — | 0 | Mar 7, 2019 · 5:20 pm EST | Form 4 |
| Elizabeth L HougenChief Financial Officer | 0 | — | 0 | Jul 13, 2017 · 8:22 pm EDT | Form 3 |
| B Lynne ParshallDirector | 0 | — | 0 | Jul 13, 2017 · 8:38 pm EDT | Form 3 |
| Stanley T CrookeDirector | 0 | — | 0 | Jul 13, 2017 · 8:40 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.